Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001824293-26-000028
Filing Date
2026-01-30
Accepted
2026-01-29 20:05:38
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 gri-sx3shelfregistrationst.htm S-3 342900
2 gri-exfilingfees.htm   iXBRL EX-FILING FEES 36437
3 EX-4.4 exhibit44-sx3jan26.htm EX-4.4 351997
4 EX-4.5 exhibit45-sx3jan26.htm EX-4.5 353870
5 EX-5.1 exhibit51-sx3jan26.htm EX-5.1 43113
6 EX-23.1 exhibit231-sx3jan26.htm EX-23.1 2608
7 image_0a.jpg GRAPHIC 18241
8 image_1a.jpg GRAPHIC 67350
9 mintzlogo.jpg GRAPHIC 256272
  Complete submission text file 0001824293-26-000028.txt   1726752

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT gri-exfilingfees_htm.xml XML 10122
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Filer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-293065 | Film No.: 26580015
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)